Lupin Pharma Canada Ltd., a wholly-owned subsidiary of Lupin Limited, has officially launched its Propranolol LA capsules in Canada, signaling a milestone in affordable healthcare solutions. The newly introduced Propranolol LA comes in four different dosages: 60 mg, 80 mg, 120 mg, and 160 mg. This medication serves as a generic alternative to the recently […]
Lupin has announced that its subsidiary in Canada, Lupin Pharma Canada has received approval from Health Canada to market a generic version of Spiriva (tiotropium bromide inhalation powder) for the treatment of chronic obstructive pulmonary disease (COPD) in Canada. Tiotropium Bromide Inhalation Powder is used as a long-term maintenance bronchodilator for patients with COPD, including […]
